| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2009 | US20090088445 Deazapurines useful as inhibitors of Janus kinases |
| 04/02/2009 | US20090088444 Substituted phenanthrene diketo acids and uses therefor |
| 04/02/2009 | US20090088443 Novel crystalline forms of conazoles and methods of making and using the same |
| 04/02/2009 | US20090088442 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism |
| 04/02/2009 | US20090088441 Quinoline Compounds |
| 04/02/2009 | US20090088440 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 04/02/2009 | US20090088439 Diazinane Compounds |
| 04/02/2009 | US20090088438 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS |
| 04/02/2009 | US20090088437 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders |
| 04/02/2009 | US20090088436 P38 Kinase Inhibiting Agents |
| 04/02/2009 | US20090088435 Methods and compounds for treating retinol-related diseases |
| 04/02/2009 | US20090088434 Antifungal Composition |
| 04/02/2009 | US20090088433 Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 04/02/2009 | US20090088432 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors |
| 04/02/2009 | US20090088431 Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| 04/02/2009 | US20090088430 hydroxysteroid reductase inhibitors such as 4-{(R)-3-[3,5-Dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-2-oxo-pyrrolidin-1-yl}-piperidine-1-carboxylic acid methyl ester, used for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia and metabolic syndrome |
| 04/02/2009 | US20090088429 Isoquinoline Derivatives |
| 04/02/2009 | US20090088428 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome |
| 04/02/2009 | US20090088427 Treatment of Vascular, Autoimmune and Inflammatory Diseases Using Low Dosages of IMPDH Inhibitors |
| 04/02/2009 | US20090088426 (3S,4R,5R)-3-hydroxymethyl-4-[4-((S)-3-methoxy-2-methyl-propoxymethyl)-phenyl]-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo [1,4]oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid benzyl ester; improvement of the pharmacokinetic properties; better bioavailability |
| 04/02/2009 | US20090088425 Glucocorticoid receptor antagonists |
| 04/02/2009 | US20090088424 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 04/02/2009 | US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/02/2009 | US20090088422 4-imidazolin-2-one compounds |
| 04/02/2009 | US20090088421 Intranasal Anti-Convulsive Compositions And Methods |
| 04/02/2009 | US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics |
| 04/02/2009 | US20090088419 Pyridyl acetic acid compounds |
| 04/02/2009 | US20090088418 4-substituted quinuclidine derivatives, methods of production, and pharmaceutical uses thereof |
| 04/02/2009 | US20090088417 Vanilloid receptor antagonist for prevention and treatment of drug dependence and addiction |
| 04/02/2009 | US20090088416 Deuterium-enriched lapaquistat |
| 04/02/2009 | US20090088415 Controlled release pharmaceutical compositions |
| 04/02/2009 | US20090088414 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
| 04/02/2009 | US20090088413 Pharmaceutical composition for topical application |
| 04/02/2009 | US20090088412 withanolide compounds extracted from a Solanaceae plant as anticancer agents; solvent extraction from Tubocapsicum anomalum |
| 04/02/2009 | US20090088411 No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties |
| 04/02/2009 | US20090088410 Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
| 04/02/2009 | US20090088409 Serum biomarkers for early detection of acute cellular rejection |
| 04/02/2009 | US20090088408 Pharmaceutical compositions on anticholinergics, corticosteroids and betamimetics |
| 04/02/2009 | US20090088407 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/02/2009 | US20090088406 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 04/02/2009 | US20090088404 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| 04/02/2009 | US20090088403 A3 adenosine receptors as targets for the modulation of central serotonergic signaling |
| 04/02/2009 | US20090088402 Novel agent for inducing apoptosis comprising msx1 or a gene encoding the same as an active ingredient |
| 04/02/2009 | US20090088401 In-situ cancer autovaccination with intratumoral stabilized dsRNA viral mimic |
| 04/02/2009 | US20090088400 Prostaglandin e2 modulation and uses thereof |
| 04/02/2009 | US20090088399 Use of Light Sensitive Genes |
| 04/02/2009 | US20090088398 Recombinant adenoviral vectors and methods of use |
| 04/02/2009 | US20090088397 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 04/02/2009 | US20090088395 Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli |
| 04/02/2009 | US20090088394 Methods and compositions for therapeutic treatment |
| 04/02/2009 | US20090088393 Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 04/02/2009 | US20090088392 Treatment of melanoma |
| 04/02/2009 | US20090088376 Dendrimer based compositions and methods of using the same |
| 04/02/2009 | US20090088373 Use of compositions to enhance innate immune response |
| 04/02/2009 | US20090088371 Combination therapy with syk kinase inhibitor |
| 04/02/2009 | US20090088368 Compositions comprising them as ppar modulators |
| 04/02/2009 | US20090088367 Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of Dementia |
| 04/02/2009 | US20090088366 Nitrosated and nitrosylated prostaglandins, compositions and methods of use |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087503 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/02/2009 | US20090087499 Depilatory product |
| 04/02/2009 | US20090087494 Methods and Compositions for Targeted Delivery of Therapeutic Agents |
| 04/02/2009 | US20090087492 Processes and Apparatuses for the Production of Crystalline Organic Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use |
| 04/02/2009 | US20090087490 Extended release formulation and method of treating adrenergic dysregulation |
| 04/02/2009 | US20090087489 Imatinib compositions |
| 04/02/2009 | US20090087488 Galantamine-containing controlled release oral dosage forms, processes for the preparation thereof and use of the manufacture of a medicament |
| 04/02/2009 | US20090087487 Paliperidone sustained release formulation |
| 04/02/2009 | US20090087484 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/02/2009 | US20090087482 Temperature-Sensitive Liposomal Formulation |
| 04/02/2009 | US20090087481 Using mixture comprising colony stimulating factor, interleukin-5 and/or a mimetic as therapeutic tool in treatment of nervous system disorders |
| 04/02/2009 | US20090087480 Pharmaceutical composition and method using antifungal agent in combination |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | US20090087470 Subcutaneously implanting a device containing octreotide or acetate salt and hydroxpropylcellulose encased in a hydrophilic addition copolymer., e.g., hydroxyethyl- hydroxypropyl methacrylate; delivers octreotide over 6 months at a controlled rate to avoid the suffering of multiple periodic injections. |
| 04/02/2009 | US20090087469 Alginate-based nanofibers and related scaffolds |
| 04/02/2009 | US20090087462 Use of pyrimidine derivatives for cosmetic purposes |
| 04/02/2009 | US20090087461 Anti-bacterial pyrocatechols and related methods |
| 04/02/2009 | US20090087460 Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these |
| 04/02/2009 | US20090087454 Method for therapeutic, clinical and veterinary use Poly-ICLC |
| 04/02/2009 | US20090087446 Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/02/2009 | US20090087443 Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery |
| 04/02/2009 | US20090087441 treating lung cancer with PI-3 kinase inhibitor acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta ,12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta [ alpha ]phenanthren-11-yl ester |
| 04/02/2009 | US20090087440 Methods for Treating Cancer |
| 04/02/2009 | US20090087436 Compositions and methods for treating diseases |
| 04/02/2009 | US20090087435 Isolated Chimeric Proteins Of Modified Lumazine Synthase |
| 04/02/2009 | US20090087434 Nfia in glial fate determination, glioma therapy and astrocytoma treatment |
| 04/02/2009 | US20090087432 TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES |
| 04/02/2009 | US20090087431 Methods of treating bone disorders with modulators of axl |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087425 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 04/02/2009 | US20090087424 Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1 |
| 04/02/2009 | US20090087420 Stable solution of reduced coenzyme q |
| 04/02/2009 | US20090087419 Licorice polyphenol preparation |
| 04/02/2009 | US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors |
| 04/02/2009 | US20090087415 Treatment of cardiovascular disorders using the cell differentiation signaling protein Nell1 |
| 04/02/2009 | US20090087413 Self-complementary aav-mediated delivery of interfering rna molecules to treat or prevent ocular disorders |
| 04/02/2009 | US20090087411 Long-acting interferons and derivatives thereof and methods thereof |
| 04/02/2009 | US20090087410 Treatment of hypersensitivity |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087407 Methods for the treatment of scleroderma using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| 04/02/2009 | US20090087406 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |